QuickLogic
This is the archived full research. Read the story
A tiny chip designer whose sales now rest on one Defense Department contract, priced as if chips it has not yet sold will succeed.
The scores
Growth2/4 ↑
Up 153% last quarter and guided up 72% for 2026, but down 30% in 2025; growth arrives in government tranches.
Business quality2/4 →
Decades-long design-ins and a captive rival help, but margins swing with contracts and Microchip and AMD dominate the chips it wants to sell.
Financial position2/4 ↑
About $11.9M of cash net of borrowings, positive cash flow over nine months, but share sales funded the year.
Execution record1/4 ↑
The 2025 plan of $24.8M closed at $13.8M, Q3 2026 missed the midpoint, and operating losses ran in five of six years.
Per share capture2/4 →
Diluted shares up about a quarter in under two years, with stock pay near a sixth of revenue.
Potential2/4 →
A real niche in an $11.73B chip market, but storefront chips and royalties are unproven and nobody sizes its market.
Risk profile2/4 ↓
Two thirds of revenue from one programme whose budget line is requested 85% lower; tranches are often delayed.
Valuation1/4 ↑
About 8.1 times sales for a business with losses in five of six years; the price needs more than the analysts' 2028 profit.
Evidence quality2/4 →
Filed revenue and cash are solid; the tranche, storefront and pipeline rest on management's words and undisclosed sizes.
If it works 0.8× · if it fails you keep about 52%.
The Verdict
We rate QuickLogic Unattractive. The business is weak: about two thirds of its sales come from one government contract to develop a radiation-proof chip, it has lost money in five of the last six years, and it sells new shares to fund itself. The budget line paying for that contract is requested sharply lower for next year. The shares are priced for perfection: at about 8 times sales it assumes the chips the government is paying to develop sell well from 2027, which no order yet shows. As a bet it is priced for success. A new government payment and a profitable fourth quarter would argue against us.
The long caseThe Defense Department keeps funding an onshore radiation-hardened FPGA, and the chips it pays to develop become products QuickLogic sells to defence and space buyers.
How we weighed it
The price against our value
Against it
No fair value is drawn: losses run in most years. The price needs more cash after stock pay than analysts expect even three years out.
The business
Against it
Weak
A weak business: long design-ins and a captive rival help, but margins swing with contracts and one customer is most of revenue.
Growth against what the price assumes
Cuts both ways
Revenue is jumping on government work after falling hard the year before; growth comes in tranches, not a steady climb.
What could go wrong
Against it
The programme's budget line is requested far lower, awards are often delayed, and the storefront needs chips not yet made.
Against competitors
Cuts both ways
Its main embedded rival went captive inside a larger chip maker, but Microchip and AMD dominate the chips it plans to offer.
How its group is behaving
Cuts both ways
Defence chips are a funded priority, but the budget line behind this programme is being cut.
The latest news and report
Cuts both ways
The last report showed fast growth but missed the midpoint, and insiders sold through the year.
The evidence under this - 8 claims
The finance chief tied Customer A to the radiation-hardened contract, so the concentration is a government programme rather than a commercial buyer who could walk away at will.
A ceiling is a maximum, not an order: each tranche is awarded separately, and the 10-K says Defense Department awards are commonly delayed six to twelve months.
Management guides a non-GAAP profit for the second half of 2026, a measure that leaves out stock pay of about $0.9M a quarter.
The record is an aggregator's copy of the budget exhibits; the radiation-hardened line remains one of four funded, and Congress can enact more than is requested.
If storefront chips or small-package antifuse parts reach management's figures, profit could pass the analysts' view well before 2028.
None of it is contracted: the development contract excludes device sales, the small-package parts have no revenue, and the company stopped quantifying its pipeline years ago.
The company
Most chips do one fixed job. A programmable chip, called an FPGA, can be rewired by its owner after it is made. QuickLogic, a 51-person company that owns no factory, sells three things: blueprints of programmable blocks that other companies build into their own chips, programmable chips of its own, including ones built to survive radiation in space, and older chips first designed decades ago.
Today its biggest job is a Defense Department contract to develop a radiation-proof programmable chip made in the United States.
The evidence under this - 3 claims
A ceiling is a maximum, not an order: each tranche is awarded separately, and the 10-K says Defense Department awards are commonly delayed six to twelve months.
A six-figure licence is small against $19.4M of revenue, and royalties start only if the customer's chip reaches volume.
How it makes money
In the third quarter of 2026, $3.9M of the $5.1M came from blueprint licences and engineering work, $1.1M from older chips and $0.15M from new chips. The finance chief put about $3.4M to $3.5M of it on the government contract alone.
One customer was 69% of the quarter's sales. QuickLogic kept 37 cents of each sales dollar after the cost of the work, against a loss on each dollar a year earlier.
The evidence under this - 4 claims
The finance chief tied Customer A to the radiation-hardened contract, so the concentration is a government programme rather than a commercial buyer who could walk away at will.
The 10-Q does not split revenue by programme; it shows only that Customer A was 69% of the quarter, which fits the figure but cannot confirm it.
Management attributes part of the margin swing to engineering costs moved between cost of revenue and operating expense, which changes the gross margin but not the loss.
Where the money comes from, stream by stream
| Stream | Share of sales (Q3 2026) | How it earns it |
|---|---|---|
| eFPGA IP and professional services | 76% | Licences of embedded FPGA designs and engineering work, mostly the government development contract. |
| Mature products | 21% | Antifuse and older FPGA chips made on processes larger than 180nm, sold mostly to defence programmes. |
| New hardware products | 3% | Newer chips and development kits, such as the radiation-hardened evaluation kit. |
Who runs it
Brian Faith joined in 1996 and has run the company since 2016; Timothy Saxe has led engineering since 2008, and a new finance chief started in September 2026. Officers and directors own 3.2% of the shares.
The 2025 bonus targeted $24.8M of sales; sales closed at $13.8M, nothing was earned, and the board then paid a one-time bonus of 75% of target. Insiders sold shares 20 times in the past year and bought none, the chief executive at $20.45 in May.
The evidence under this - 4 claims
The September sales by three officers came days after scheduled share awards vested, so some may have covered tax on those awards rather than expressed a view.
Why it wins, and who could beat it
Why customers come back
Once a programmable block or an older chip is designed into a defence system, the customer needs the same supplier for the life of the programme, often decades, because switching means a new design and new testing. That is why chips introduced long ago still sell.
Its one independent rival in blueprints, Flex Logix, was taken over by Analog Devices in 2024 and now serves its owner, and QuickLogic says it has won back one of its designs. It holds 22 US patents.
The evidence under this - 4 claims
Terms were not disclosed and Analog Devices may still license the designs; the captive reading is QuickLogic's chief executive's.
The 10-K names no eFPGA rival at all, and nothing filed confirms either win-back.
The threat
In finished programmable chips QuickLogic is tiny against AMD, Intel's former unit Altera, Lattice and Microchip, whose Microsemi line already sells radiation-proof chips to space and defence buyers. In blueprints, Analog Devices now owns Flex Logix's technology, and big chip makers can design their own programmable blocks.
The evidence under this - 3 claims
Terms were not disclosed and Analog Devices may still license the designs; the captive reading is QuickLogic's chief executive's.
The rivals: MCHP, AMD, LSCC, ADI, and 1 more that is private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | Where it competes | How far along | Priced against it |
|---|---|---|---|---|
| MCHP | Microchip's radiation-tolerant FPGAs (from Microsemi)Priced against it: One segment only | Storefront chips: radiation-hardened FPGAs, chiplets and small-package antifuse parts | On sale | One segment only |
| AMD | AMD's Xilinx FPGAs, including space-grade partsPriced against it: One segment only | Storefront chips: radiation-hardened FPGAs, chiplets and small-package antifuse parts | On sale | One segment only |
| LSCC | Lattice Semiconductor's low-power FPGAsPriced against it: One segment only | eFPGA IP licences, government development contracts and mature FPGAs | On sale | One segment only |
| ADI | Analog Devices, owner of the Flex Logix embedded FPGA technologyPriced against it: Not checked | eFPGA IP licences, government development contracts and mature FPGAs | On sale | Not checked |
| In-house | Customers' own fixed-function chip designsPriced against it: In-house | eFPGA IP licences, government development contracts and mature FPGAs | On sale | In-house |
How big it could get
How big this could get
Programmable chips are about an $11.7B market worldwide, and QuickLogic's last year of sales is about 0.17% of it. Nobody publishes how much is spent on radiation-proof programmable chips or on blueprints, so its real market cannot be counted. Management's long-term goal is about $100M of sales a year; the Defense Department programme behind its contract was funded at about $1.06B for 2026.
The evidence under this - 4 claims
A paid market report sizes discrete chips sold by the large makers and says nothing about embedded FPGA licences or radiation-hardened parts, QuickLogic's actual markets.
Most of QuickLogic's revenue is development work and licences, which a market for chips does not count, so the share understates its place in its niche.
The record is an aggregator's copy of the budget exhibits; the radiation-hardened line remains one of four funded, and Congress can enact more than is requested.
None of it is contracted: the development contract excludes device sales, the small-package parts have no revenue, and the company stopped quantifying its pipeline years ago.
The results
The numbers
Sales grew 27% over the twelve months to Sep 2026, faster than the −30% in the year to Dec 2025.
Operating margin is −49%, down from 0.3% in the year to Dec 2023.
Running costs take 84¢ of each sales dollar, down from 118¢ in the year to Jan 2022.
Shareholders' money lost 41% a year, up from −61% in the year to Jan 2022.
It turned 6.5% of sales into free cash, $1.27M over the last twelve months.
Yearly sales growth has ranged from −30% to +47% over the last 5 years, with sales falling in 2 of them.
The share count rose 27% in 1.7 years, and pay in shares costs 3.8% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-17. Fiscal years end in December.
| Jan 2022 | Jan 2023 | Dec 2023 | Dec 2024 | Dec 2025 | 12 mo to Sep 2026 | |
|---|---|---|---|---|---|---|
| Size and growth | ||||||
| Sales | $12.7M | $16.2M | $21.2M | $19.7M | $13.8M | $19.4M |
| Sales growth | +47% | +28% | +31% | −7.3% | −30% | +27% |
| Profit | ||||||
| Gross margin | 58% | 54% | 68% | 62% | 22% | 35% |
| Operating margin | −59% | −23% | 0.3% | −13% | −87% | −49% |
| Net margin | −52% | −26% | −1.2% | −20% | −108% | −58% |
| What growth costs, per sales dollar | ||||||
| Research and development | 55% | 31% | 30% | 30% | 38% | 31% |
| Selling, general and admin | 63% | 47% | 38% | 45% | 67% | 53% |
| Pay in shares | 20% | 13% | 12% | 23% | 24% | 3.8% |
| Capital spending | 1.4% | 0.9% | 26% | 27% | 23% | 1.6% |
| Cash | ||||||
| Cash from operations | −$2.86M | −$4.06M | $4.85M | $27.0K | −$3.26M | $1.57M |
| Free cash flow | −$3.04M | −$4.20M | −$620K | −$5.38M | −$6.43M | $1.27M |
| Balance sheet | ||||||
| Debt | $15.0M | $15.9M | $1.40M | $3.10M | $2.98M | $2.43M |
| Returns and shares | ||||||
| Shares (diluted) | - | - | - | 14.5M | 16.2M | 18.4M |
What growth costs
There is no steady answer yet. The share of each sales dollar kept after costs swung from 61.5% in 2024 to 22.0% in 2025 and 37.4% last quarter, because engineers working on contracts count as a cost of the sale. Stock pay near a sixth of sales has never been covered by profit.
The evidence under this - 3 claims
Management attributes part of the margin swing to engineering costs moved between cost of revenue and operating expense, which changes the gross margin but not the loss.
Engineering costs on contracts sit in cost of revenue, so the margin falls with revenue more than in a product company.
The last report (10 Nov)
Quarter ended September 2026, filed figures.
In the third quarter of 2026, sales rose 153% to $5.1M, but came in below the middle of the company's own range because a customer widened a contract and pushed its signing into the fourth quarter. It kept 37 cents of each sales dollar and lost $2.1M before interest and tax.
Over nine months operations brought in $3.5M of cash. For the fourth quarter it expects about $8M of sales and a small profit on its own adjusted measure.
What it did to the thesisIt helped the business case a little: sales grew fast and the business brought in cash. It did not change the case, because the growth is one development contract, the loss continued, and the fourth quarter has to carry the year.
The quarter in detail
Sales growth from the previous quarter, filed figures. The company has restated its own history, so a quarter either side of the restatement may describe a different business; n/c marks one that does not compare.
Earnings per share $-0.07 against $-0.05 expected; $-0.12 as filed, the gap being what the company adds back.
The evidence under this - 5 claims
Q3 2026 revenue fell 6.3% from the second quarter and came in below the midpoint of management's guidance.
Management attributes part of the margin swing to engineering costs moved between cost of revenue and operating expense, which changes the gross margin but not the loss.
About five contracts still have to be signed for the quarter, the Intel 18A-P contract already slipped out of the third quarter, and the 2025 plan of $24.8M closed at $13.8M.
A contract that slipped once can slip again, and the customer is not named.
The finance chief said third-quarter cash flow was flattered by payments made in the fourth quarter instead.
What management did with the money
QuickLogic pays for its losses partly by selling new shares into the market: 903,000 shares for $9.5M in the first nine months of 2026, after $4.4M a year earlier. Stock pay of about $3.4M a year adds more shares. It spent $1.7M on equipment and design software over nine months.
Insiders in 2026Q3: 21 purchases and 18 sales, from their Form 4 filings.
The evidence under this - 3 claims
The finance chief said third-quarter cash flow was flattered by payments made in the fourth quarter instead.
The price, and where we disagree
In short. Priced for perfection. The price needs more profit than analysts expect even three years out, from chips nobody has ordered.
The shares are 62.8% below their high of the past year: buyers now pay much less for each dollar of sales, while sales per share rose. About 9% of the shares available to trade are sold short.
The next test is the fourth-quarter report, due around 2 March 2027: whether sales reached about $8M, the next government payment arrived and the business made a profit without selling shares.
The evidence under this - 4 claims
The chief executive said the company does not know when a tranche arrives until it arrives, and would not give its size.
About five contracts still have to be signed for the quarter, the Intel 18A-P contract already slipped out of the third quarter, and the 2025 plan of $24.8M closed at $13.8M.
How we value it
No fair value: QuickLogic has filed an operating loss in five of six years and the analysts' last forecast margin after stock pay is near zero, so a value built on earnings would rest on a guess; the bet prices it instead.
How we read the multiple
With no lasting profit to price, we ask what profit the price needs.
- The whole company, adding its debt and netting its cash, is worth about $158M.
- A rule of thumb: a buyer wants 8% a year and a mature business grows 4%, so 4% must come back as cash.
- That is about $6.3M a year after stock pay.
- Analysts' 2028 figures leave about $2.3M after stock pay.
- Over the last four quarters it lost $9.4M before interest and tax.
Against its own history. Buyers pay far less for each dollar of sales than six months ago; the fall came from the price, not from the sales.
The evidence under this - 4 claims
If storefront chips or small-package antifuse parts reach management's figures, profit could pass the analysts' view well before 2028.
Two or three analysts make each figure, and the operating profit is likely on the adjusted basis that leaves out stock pay.
Priced against its rivals
None of the listed rivals above sells the same thing to the same buyers as a large part of what it does. A price comparison needs at least two, so the price is judged against its own history instead.
Private or foreign rivals that cannot be priced: Altera, Flex Logix Technologies, Achronix Semiconductor, Menta SAS.
The bet: what it pays if it works
This bet is on QuickLogic selling its own chips. If those reach about $10M of sales a year and buyers pay 5 times sales for them, while the rest of the company is valued at 3 times sales, the shares would still be worth less than today.
If the chips never sell, the rest of the company is worth about half of today's price.
| Storefront chips: radiation-hardened FPGAs, chiplets and small-package antifuse parts revenue in two to three years | Million dollars of storefront chip sales a year needed | At the stated multiple |
|---|---|---|
| $1.50M | about 2 at 100% kept | 0.5× |
| $10.00M (the big win) | about 10 at 100% kept | 0.8× |
| $25.00M | about 25 at 100% kept | 1.3× |
To pay 2× (a Fair bet) it would need about $47.09M of Storefront chips: radiation-hardened FPGAs, chiplets and small-package antifuse parts revenue (about 47 million dollars of storefront chip sales a year); to pay 5× (a Cheap bet), about $139.07M of Storefront chips: radiation-hardened FPGAs, chiplets and small-package antifuse parts revenue (about 139 million dollars of storefront chip sales a year), at the same multiple.
Each row is Storefront chips: radiation-hardened FPGAs, chiplets and small-package antifuse parts alone, plus the rest of the company (eFPGA IP licences, government development contracts and mature FPGAs) counted at about $71.10M.
The steps it has to take
- Done Government contract ceiling raised to $88M and a $13M tranche awarded
- Done Radiation-hardened development kits delivered to customers
- In progress Next government tranche awarded, funding two tape-outs due 2026-12
- In progress 12LP evaluation kit released due 2026-12
- Not started First small-package antifuse revenue due 2027-06
- Not started First storefront radiation-hardened chip sales due 2027-12
The detail behind the label
The evidence under this - 4 claims
None of it is contracted: the development contract excludes device sales, the small-package parts have no revenue, and the company stopped quantifying its pipeline years ago.
The chief executive said the company does not know when a tranche arrives until it arrives, and would not give its size.
Management guides a non-GAAP profit for the second half of 2026, a measure that leaves out stock pay of about $0.9M a quarter.
Management quotes $14.2M of net cash because it leaves the notes payable out, and says third-quarter cash benefited from payments that slipped into the fourth.
Where we disagree with the market
A small defence chip company with a funded programme, cheap enough after its fall to jump on the next government payment.
The sales are one development contract whose budget is shrinking, and the chip plan has no buyer yet.
The market sees a funded defence chip programme and a plan to sell its own chips, now cheap after a 63% fall. We see a company whose sales are development work paid by one programme, whose budget line is being cut, with no chip order behind the plan.
The evidence against us: a new government payment at or above this year's, and storefront orders in 2027, would show the plan working.
What analysts say, and the evidence
The evidence under this - 6 claims
None of it is contracted: the development contract excludes device sales, the small-package parts have no revenue, and the company stopped quantifying its pipeline years ago.
The chief executive said the company does not know when a tranche arrives until it arrives, and would not give its size.
The record is an aggregator's copy of the budget exhibits; the radiation-hardened line remains one of four funded, and Congress can enact more than is requested.
The finance chief tied Customer A to the radiation-hardened contract, so the concentration is a government programme rather than a commercial buyer who could walk away at will.
What could go wrong, and how we would know
The risks
- One contract. About two thirds of sales come from one Defense Department programme.
- The budget shrinks. Its budget line is requested about 85% lower for 2027, and payments are often late.
- Losses and new shares. Five loss years in six, paid for partly by selling shares.
- Giant rivals. Microchip already sells radiation-proof programmable chips, and AMD and Lattice dwarf it.
The evidence under this - 6 claims
The finance chief tied Customer A to the radiation-hardened contract, so the concentration is a government programme rather than a commercial buyer who could walk away at will.
The record is an aggregator's copy of the budget exhibits; the radiation-hardened line remains one of four funded, and Congress can enact more than is requested.
Management guides a non-GAAP profit for the second half of 2026, a measure that leaves out stock pay of about $0.9M a quarter.
What we still do not know
- When the next government payment comes, and how large it is.
- Whether anyone orders the radiation-proof chips once the government stops paying for development.
- Whether the delayed contract for a large blueprint on Intel's newest process is signed.
The evidence under this - 3 claims
The chief executive said the company does not know when a tranche arrives until it arrives, and would not give its size.
None of it is contracted: the development contract excludes device sales, the small-package parts have no revenue, and the company stopped quantifying its pipeline years ago.
A contract that slipped once can slip again, and the customer is not named.
What would change our view
- Unattractive→NeutralThe business pays for itself
It needs all of:
- ○Operating income over four quarters turns positive.checked at the next results, due by 2 Mar
- ○Sales over four quarters rise above $30M.checked at the next results, due by 2 Mar
- Unattractive→NeutralA price that stops assuming the storefront
It needs:
- ○The whole company's value falls to 4 times its last year's sales.about ≈$4.44 today, 51% below the last close
We would also be wrong if
- No new government payment is announced by the end of March 2027.
- Fourth-quarter 2026 sales finish below $7.2M, the bottom of the company's range.
- More than $10M of new shares are sold in 2027.
What is coming
- 31 December 2026 Next Strategic Radiation Hardened contract tranche: Whether the government keeps funding the programme that brings two thirds of revenue, and at what size.
Every dated event ahead
- 31 December 2026 Next Strategic Radiation Hardened contract tranche: Whether the government keeps funding the programme that brings two thirds of revenue, and at what size.
- 2 March 2027 Q4 2026 results: Whether the fourth quarter reached about $8M with a non-GAAP profit and breakeven cash flow.
- 30 June 2027 Two radiation-hardened FPGA tape-outs: Whether the chips the storefront will sell are on schedule for late 2027.
Since we wrote this
- 17 NovThesis writtenUnattractive, medium convictionWritten a week after the Q3 2026 results, with the shares 63% below their May high.
Sources 16
Sources - 16
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-03-27the business, the named competitors, customer concentration, government contracts as a share of sales, headcount, patents, manufacturing and the risk factorsbacksC01C02C04C08C11C14C17C21C33C34C35C39C40
- S02primarycompany filing2026-11-12revenue by product family, customer concentration, cash, the revolving credit facility and its covenants, notes payable, the at-the-market sales, stock pay, cash flows and remaining obligationsbacksC01C02C03C04C07C10C11C12C13C27C30C38
- S03primarycompany release2026-11-10the quarter's revenue, margins, losses, balance sheet, the automotive design win and the new finance chiefbacksC02C07C36C39
- S04primarytranscript2026-11-10the fourth-quarter outlook, the next government tranche, the storefront plan, the revenue split by programme, the Flex Logix win-back and the pipeline
Based on backlog and customer forecasts, our total revenue guidance for Q4 2026 is $8 million plus or minus 10%.
backsC06C09C12C18C19C24C25C26C36C37 - S05primarycompany filing2026-03-27the 2025 bonus goals and their outcome, the one-time bonus, and the ownership tablebacksC14C15
- S06primarycompany release2025-12-18the contract's sponsor, technical lead and ceiling
With this, the total ceiling value has been increased to $88 million over multiple years.
backsC05 - S07primarycompany release2026-02-18the 2026 tranche
QuickLogic Corporation (NASDAQ: QUIK ), a developer of embedded FPGA (eFPGA) Hard IP, ruggedized FPGAs, and endpoint AI solutions, announced today it has been awarded a $13 million contract.
backsC05 - S08primarycompany release2026-05-13the discrete FPGA test chip contract and the evaluation kit
announced today it has been awarded a new contract for a large discrete FPGA with a ceiling value of $2.7 million.
backsC25 - S09secondarynews2024-11-08that the main independent eFPGA rival's technology and team went to Analog Devices
The 10-year-old company's technology assets and technical team will transfer to ADI.
backsC18 - S10secondarygovernment data2026-11-17the programme's description, its FY2026 enacted $1,061.3M and FY2027 request of $156.7M, republished from the Department of Defense budget exhibits
DoW Unique Needs RADHARD responds to reliance on a small supplier base for radiation-hardened integrated circuits and specialized components needed in space and other harsh environments.
backsC22 - S11secondaryindustry data2025-10-28the size of the FPGA chip market
The global field-programmable gate array (FPGA) market is poised for major growth, increasing from $11.73 billion in 2025 to $19.34 billion by 2030, according to a new report from MarketsandMarkets.
backsC21 - S12primarycompany filing2026-05-21that FPGAs are a strategic line inside a much larger rival
Our strategic focus includes general purpose and specialized mixed-signal microcontrollers, microprocessors, analog, FPGA, data center, networking, and memory products.
backsC20 - S13primarycompany filing2026-02-04who the largest FPGA maker counts as its rivals
We expect continued competition from our primary FPGA competitors such as Altera, Lattice Semiconductor Corporation and Microsemi Corporation
backsC20 - S14secondaryvendor data2026-11-17Research pack (FMP market tier and FINRA short interest), frozen 2026-11-17content/QUIK/research-pack.jsonthe close, market value, returns, the price-move decomposition, the analyst split and estimates, and short interestbacksC28C29C30C31
- S15primarycompany filing2026-09-18each open-market sale, its price and whether it was made under a pre-set planbacksC16
- S16primarycompany filing2026-11-17six years of filed revenue, operating income, stock pay and diluted shares, frozen in content/QUIK/financials.jsonbacksC08C11C12C13C33C40